297 related articles for article (PubMed ID: 26005980)
1. Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil.
Romero FR; Xavier LR; Romero AW; Almeida RM; Matias JE; Tambara Filho R
Int Braz J Urol; 2015; 41(2):360-6. PubMed ID: 26005980
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
3. Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Catalona WJ; Partin AW; Slawin KM; Naughton CK; Brawer MK; Flanigan RC; Richie JP; Patel A; Walsh PC; Scardino PT; Lange PH; deKernion JB; Southwick PC; Loveland KG; Parson RE; Gasior GH
Urology; 2000 Mar; 55(3):372-6. PubMed ID: 10699613
[TBL] [Abstract][Full Text] [Related]
4. Race and the linkage between serum prostate-specific antigen and prostate cancer: a study of American veterans.
Vollmer RT
Am J Clin Pathol; 2004 Sep; 122(3):338-44. PubMed ID: 15362363
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
6. Biopsy core length in white versus African descendant prostate cancer patients.
Azal Neto W; Andrade GM; Billis A; Reis LO
Scand J Urol; 2020 Jun; 54(3):188-193. PubMed ID: 32343184
[No Abstract] [Full Text] [Related]
7. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
Abdalla I; Ray P; Vaida F; Vijayakumar S
Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
[TBL] [Abstract][Full Text] [Related]
8. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
Latchamsetty KC; Kim J; Porter CR
J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.
Vijayakumar S; Winter K; Sause W; Gallagher MJ; Michalski J; Roach M; Porter A; Bondy M
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):17-25. PubMed ID: 9422553
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis.
Romero FR; Romero AW; Almeida RM; Tambara Filho R
Int Braz J Urol; 2012; 38(4):440-7. PubMed ID: 22951172
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.
Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS
J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891
[TBL] [Abstract][Full Text] [Related]
14. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
Asbell SO; Vijayakumar S
Prostate; 1997 Apr; 31(1):42-6. PubMed ID: 9108885
[TBL] [Abstract][Full Text] [Related]
17. Age-specific reference ranges for serum prostate-specific antigen in black men.
Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
[TBL] [Abstract][Full Text] [Related]
18. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
Fowler JE; Bigler SA; Kilambi NK; Land SA
Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
Etzioni R; Berry KM; Legler JM; Shaw P
Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
